Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
This study has been completed.
Study NCT00368862 Information provided by National Institute for Health and Welfare, Finland
First Received: August 28, 2006 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcoholism
Depression
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Alcohol-Related Disorders
Behavioral Symptoms
Disorders of Environmental Origin
Mental Disorders
Mood Disorders
Substance-Related Disorders
Interventions listed in this trial
Ebixa (memantine hydrochloride)
Cipralex (escitalopram)
Additional drug interventions recognized in this trial
Citalopram
Dexetimide
Memantine
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Dopamine Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Institute for Health and Welfare, Finland
Finnish Foundation for Alcohol Studies
Back to top of Main Content
